Silencing of Polo-Like Kinase (Plk) 1 via siRNA Causes Inhibition of Growth and Induction of Apoptosis in Human Esophageal Cancer Cells

Publisher： Karger

E-ISSN： 1423-0232|74|3-4|198-206

ISSN： 0030-2414

Source： Oncology, Vol.74, Iss.3-4, 2008-08, pp. : 198-206

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overexpression of Polo-Like Kinase 1 (PLK1) and Chromosomal Instability in Bladder Cancer

By  

Oncology, Vol. 70, Iss. 3, 2006-07 ,pp. : 231-237

Karger

Access to resources Recommend Favorite

Expression of Polo-Like Kinase 1 (PLK1) Protein Predicts the Survival of Patients with Gastric Carcinoma

By  

Oncology, Vol. 70, Iss. 2, 2006-05 ,pp. : 126-133

Karger

Access to resources Recommend Favorite

Overexpression of Polo-Like Kinase 1 Is a Common and Early Event in Pancreatic Cancer

By  

Pancreatology, Vol. 5, Iss. 2-3, 2005-05 ,pp. : 259-265

Karger

Access to resources Recommend Favorite

RNA Interference-Mediated Silencing of the Phosphatidylinositol 3-Kinase Catalytic Subunit Attenuates Growth of Human Ovarian Cancer Cells in vitroand in vivo

By  

Oncology, Vol. 77, Iss. 1, 2009-05 ,pp. : 22-32

Karger

Access to resources Recommend Favorite

Comprehensive Biomarker Analyses in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Prospectively Treated with the Polo-Like Kinase 1 Inhibitor BI2536

By  

Oncology Research and Treatment, Vol. 40, Iss. 7-8, 2017-06 ,pp. : 435-439

Karger

Access to resources Recommend Favorite